https://www.live-feeds.com/feed/no-more-nordisk-as-novo-goes-it-alone-amid-rebranding-pushContinuously updated, source-cited coverage. https://www.live-feeds.com/feed/no-more-nordisk-as-novo-goes-it-alone-amid-rebranding-pushhttps://www.live-feeds.com/feed/no-more-nordisk-as-novo-goes-it-alone-amid-rebranding-push#u70363Wed, 16 Sep 2026 12:06:27 +0000Drugmaker Novo Nordisk has dropped the Nordisk moniker from its day-to-day identity, shortening its name to Novo alongside a cultural reset and corporate changes. The strategic shift comes as the company fights to boost recognition and regain lost market share in the obesity-drug sector. The rebrand arrives during a challenging period for the firm, which recently logged its worst stock week since February amid mounting competitive pressure from rival Eli Lilly. The corporate overhaul marks a new chapter for the company as its new chief executive officer charts a turnaround strategy.Why it matt